Dr. Stuart Weiss discusses preferred diabetes medications and new diabetes technologies, such as CGMs.
Read More »Cause of Low Mortality Rate from Coronary Heart Disease
Increase in BMI and A1c leads to coronary issues.
Read More »Prediabetes Risk Unrecognized by Most PCPs
Only 6% of PCP’s were able to identify 11 prediabetes risk factors (there are actually 13) that would prompt them to screen patients under the ADA guidelines according to a new study. Are you any better?
Read More »Diabetic Peripheral Neuropathy In Young Adults
Long-term uncontrolled glycemic levels primary cause of complication.
Read More »Beta Blockers And the Risk of CV Events in Type 2 Diabetes
Beta-blocker use in patients with T2DM and established CV risk factors associated with increased risk of CV events and severe hypoglycemia, according to recent study.
Read More »CDC: 100 Million Have Diabetes or Prediabetes
The growth of diabetes in the United States may be slowing, but it is still increasing. Just how bad can it get?
Read More »Lipid-Lowering Effect of Extra Virgin Olive Oil and Atorvastatin in Type 2 Diabetes
Extra virgin olive oil, like statins, promotes lipid lowering in people with diabetes who have dyslipidemia.
Read More »Estimating Concentrations of Chromium and Manganese in Diabetes Patients
Serum concentration levels of both chromium and manganese metals are altered in people with and without diabetes.
Read More »Link Between Serum Bilirubin and Diabetic Retinopathy in Type 2 Diabetes Patients
Serum bilirubin is inversely correlated with diabetic retinopathy predicting progression of retinopathy over time.
Read More »Even More Protection for the Kidneys With An SGLT-2 Inhibitor (And a comment from George Bakris, MD)
New data from the EMPA-REG-OUTCOME study provide more evidence of the renoprotective effects of empagliflozin in patients with type 2 and cardiovascular disease.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.